Primary and radiation induced skull base osteosarcoma: a systematic review of clinical features and treatment outcomes Othman Bin AlamerAli S. HaiderTarek Y. El Ahmadieh Topic Review 17 May 2021 Pages: 183 - 202
Current experimental therapies for atypical and malignant meningiomas Andres M. CoronaLong DiMichael E. Ivan Topic Review 05 May 2021 Pages: 203 - 210
Evaluation of Ac-Lys0(IRDye800CW)Tyr3-octreotate as a novel tracer for SSTR2-targeted molecular fluorescence guided surgery in meningioma Bianca M. DijkstraMarion de JongRob J. M. Groen Laboratory Investigation Open access 26 March 2021 Pages: 211 - 222
Correction to: Evaluation of Ac-Lys0(IRDye800CW)Tyr3-octreotate as a novel tracer for SSTR2-targeted molecular fluorescence guided surgery in meningioma Bianca M. DijkstraMarion de JongRob J. M. Groen Correction Open access 20 May 2021 Pages: 223 - 223
Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival Erin E. CrottyStephanie M. C. SmithJames M. Olson Laboratory Investigation 08 May 2021 Pages: 225 - 237
The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring Conor S. GillespieAbdurrahman I. IslimMichael D. Jenkinson Clinical Study Open access 22 April 2021 Pages: 239 - 249
Quantitative mapping of individual voxels in the peritumoral region of IDH-wildtype glioblastoma to distinguish between tumor infiltration and edema Archya DasguptaBenjamin GeraghtyGregory J. Czarnota Clinical Study 27 April 2021 Pages: 251 - 261
A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma Fatma E. El-KhoulySophie E. M. Veldhuijzen van ZantenGertjan J. L. Kaspers Clinical Study Open access 07 May 2021 Pages: 263 - 271
Long-term outcomes of grade I/II skull base chondrosarcoma: an insight into the role of surgery and upfront radiotherapy Hirotaka HasegawaKunal VakhariaMichael J. Link Clinical Study 27 April 2021 Pages: 273 - 281
PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression Jonathan WellerSophie KatzendoblerJoerg-Christian Tonn Clinical Study Open access 01 May 2021 Pages: 283 - 291
Retrospective study of diffuse intrinsic pontine glioma in the Belgian population: a 25 year experience Dries RuttensJulie MessiaenSandra Jacobs Clinical Study 03 May 2021 Pages: 293 - 301
3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas Jim ZhongVicki HuangBrent D. Weinberg Clinical Study 13 May 2021 Pages: 303 - 311
Clinical characteristics and management differences for grade II and III spinal meningiomas William E. KraussYagiz Ugur YolcuMohamad Bydon Clinical Study 10 May 2021 Pages: 313 - 320
Differences in treatment patterns and overall survival between grade II and anaplastic pleomorphic xanthoastrocytomas Adrian RodriguesHriday BhambhvaniMelanie Hayden-Gephart Clinical Study 10 May 2021 Pages: 321 - 330
Microsurgical resection of foramen magnum meningioma: multi-institutional retrospective case series and proposed surgical risk scoring system Nida FatimaJohn H. ShinAntonio Meola Clinical Study 10 May 2021 Pages: 331 - 342
Early hormonal recovery following endoscopic transsphenoidal surgery for silent non-functioning pituitary adenomas with hormone dysfunction Min Ho LeeKyu Yeon HurDoo-Sik Kong Clinical Study 17 May 2021 Pages: 343 - 350
Effect of adjuvant radiotherapy after subtotal resection for WHO grade I meningioma: a propensity score matching analysis of the Brain Tumor Registry of Japan Soichi OyaFusao IkawaYoshitaka Narita Clinical Study 17 May 2021 Pages: 351 - 360
Impact of the extent of resection on the survival of patients with grade II and III gliomas using awake brain mapping Kazuya MotomuraLushun ChaliseRyuta Saito Clinical Study 19 May 2021 Pages: 361 - 372
Sonodynamic therapy for metastatic melanoma to the brain Darrah SheehanKimball SheehanJason Sheehan Letter to the Editor 10 May 2021 Pages: 373 - 374